Business Chief Magazine October 2026 | Page 41

TOP 10 | SOCIAL IMPACT CEOs

09

WATCH NOW
Novartis CEO Vas Narasimhan on drug development & AI’ s role in disease treatment

Vas Narasimhan

Company: Novartis Revenue: US $ 50bn Employees: 76,000 Founded: 1996
Vas Narasimhan, the Harvard-trained physician running Novartis, argues a drugmaker’ s social impact is the drug itself, and prices some of Novartis’ s accordingly. Novartis runs global health programmes targeting malaria, leprosy and sickle cell disease across sub-Saharan Africa, pairing them with access plans that put newer therapies into low-income markets at not-for-profit prices. It is philanthropy with a supply chain, run by a CEO who still talks like an epidemiologist. businesschief. com 41